» Articles » PMID: 32580910

Erratum to "Biparameteric Prostate MRI and Clinical Indicators Predict Clinically Significant Prostate Cancer in Men with "gray Zone" PSA Levels" [Eur. J. Radiol. 127 (2020) 108977]

Overview
Journal Eur J Radiol
Specialty Radiology
Date 2020 Jun 26
PMID 32580910
Citations 1
Authors
Affiliations
Soon will be listed here.
Citing Articles

The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy in clinically significant prostate cancer detection in patients with biopsy-naïve men according to PSA levels: A propensity score matching analysis.

Byun H, Shin T, Jung W, Ha J, Kim B, Kim Y Prostate Int. 2022; 10(1):45-49.

PMID: 35510102 PMC: 9042765. DOI: 10.1016/j.prnil.2021.10.002.